{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T13:43:42Z","timestamp":1778247822314,"version":"3.51.4"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T00:00:00Z","timestamp":1748476800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82272854"],"award-info":[{"award-number":["82272854"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Oncology"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.tranon.2025.102436","type":"journal-article","created":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T18:40:44Z","timestamp":1749321644000},"page":"102436","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["KAT5 promotes tumor growth in androgen-independent prostate cancer by facilitating aerobic glycolysis"],"prefix":"10.1016","volume":"58","author":[{"given":"Wei","family":"He","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juping","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chenghe","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fukang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tranon.2025.102436_bib0001","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1056\/NEJMcp2209151","article-title":"Screening for prostate cancer","volume":"388","author":"Pinsky","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tranon.2025.102436_bib0002","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global Cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.tranon.2025.102436_bib0003","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.semradonc.2016.08.002","article-title":"Prostate cancer genetics: variation by race, ethnicity, and geography","volume":"27","author":"Rebbeck","year":"2017","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.tranon.2025.102436_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.215927","article-title":"Prostate cancer treatment - China's perspective","volume":"550","author":"Liu","year":"2022","journal-title":"Cancer Lett."},{"key":"10.1016\/j.tranon.2025.102436_bib0005","doi-asserted-by":"crossref","first-page":"675","DOI":"10.2174\/1389557516666160923125031","article-title":"Tip60: main functions and its inhibitors","volume":"17","author":"Zhang","year":"2017","journal-title":"Mini Rev Med Chem"},{"key":"10.1016\/j.tranon.2025.102436_bib0006","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s13353-018-0432-y","article-title":"Tip60: updates","volume":"59","author":"Ghobashi","year":"2018","journal-title":"J. Appl. Genet."},{"key":"10.1016\/j.tranon.2025.102436_bib0007","first-page":"3195","article-title":"Tip60-siRNA regulates ABCE1 acetylation to suppress lung cancer growth via activation of the apoptotic signaling pathway","volume":"17","author":"Liang","year":"2019","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.tranon.2025.102436_bib0008","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1007\/s13258-022-01298-x","article-title":"Regulation of UHRF1 acetylation by TIP60 is important for colon cancer cell proliferation","volume":"44","author":"Hong","year":"2022","journal-title":"Genes Genomics"},{"key":"10.1016\/j.tranon.2025.102436_bib0009","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.2217\/epi-2018-0004","article-title":"TIP60: an actor in acetylation of H3K4 and tumor development in breast cancer","volume":"10","author":"Judes","year":"2018","journal-title":"Epigenomics"},{"key":"10.1016\/j.tranon.2025.102436_bib0010","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.1111\/cas.15785","article-title":"TIP60 is required for tumorigenesis in non-small cell lung cancer","volume":"114","author":"Shibahara","year":"2023","journal-title":"Cancer Sci."},{"key":"10.1016\/j.tranon.2025.102436_bib0011","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.886594","article-title":"Lysine acetyltransferases and their role in AR signaling and prostate cancer","volume":"13","author":"Jaiswal","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.tranon.2025.102436_bib0012","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21186622","article-title":"Metabolic roles of androgen receptor and Tip60 in androgen-dependent prostate cancer","volume":"21","author":"Tan","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.tranon.2025.102436_bib0013","first-page":"20","article-title":"The molecular effects of sulforaphane and Capsaicin on metabolism upon androgen and Tip60 activation of androgen receptor","author":"Carrasco-Pozo","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.tranon.2025.102436_bib0014","first-page":"368","article-title":"Metabolic reprogramming and cancer progression","author":"Faubert","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.tranon.2025.102436_bib0015","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1158\/0008-5472.CAN-21-2988","article-title":"EIF4A3-Induced circARHGAP29 promotes aerobic glycolysis in docetaxel-resistant prostate cancer through IGF2BP2\/c-Myc\/LDHA signaling","volume":"82","author":"Jiang","year":"2022","journal-title":"Cancer Res."},{"key":"10.1016\/j.tranon.2025.102436_bib0016","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1186\/s12885-023-10685-w","article-title":"NPAS2 promotes aerobic glycolysis and tumor growth in prostate cancer through HIF-1A signaling","volume":"23","author":"Ma","year":"2023","journal-title":"BMC Cancer"},{"key":"10.1016\/j.tranon.2025.102436_bib0017","doi-asserted-by":"crossref","first-page":"594","DOI":"10.4149\/neo_2022_211021N1497","article-title":"LncRNA NEAT1-associated aerobic glycolysis blunts tumor immunosurveillance by T cells in prostate cancer","volume":"69","author":"Xia","year":"2022","journal-title":"Neoplasma"},{"key":"10.1016\/j.tranon.2025.102436_bib0018","first-page":"10","article-title":"HO-1 modulates aerobic glycolysis through LDH in prostate cancer cells","author":"Cascardo","year":"2021","journal-title":"Antioxidants (Basel, Switzerland)"},{"key":"10.1016\/j.tranon.2025.102436_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2022.103752","article-title":"Inhibition of acetylation, is it enough to fight cancer?","volume":"176","author":"L\u00f3pez-Ba\u00f1uelos","year":"2022","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.tranon.2025.102436_bib0020","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1038\/nature06055","article-title":"Tip60 is a haplo-insufficient tumour suppressor required for an oncogene-induced DNA damage response","volume":"448","author":"Gorrini","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.tranon.2025.102436_bib0021","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1038\/nature03452","article-title":"Transcriptional regulation of a metastasis suppressor gene by Tip60 and beta-catenin complexes","volume":"434","author":"Kim","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.tranon.2025.102436_bib0022","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1038\/sj.onc.1206342","article-title":"Expression of Tip60, an androgen receptor coactivator, and its role in prostate cancer development","volume":"22","author":"Halkidou","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.tranon.2025.102436_bib0023","first-page":"2864","article-title":"KAT5 and KAT6B are in positive regulation on cell proliferation of prostate cancer through PI3K-AKT signaling","volume":"6","author":"He","year":"2013","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1016\/j.tranon.2025.102436_bib0024","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1080\/19768354.2019.1644372","article-title":"KAT5 Negatively regulates the proliferation of prostate cancer LNCaP cells via the caspase 3-dependent apoptosis pathway","volume":"23","author":"Kim","year":"2019","journal-title":"Animal Cells Syst (Seoul)"},{"key":"10.1016\/j.tranon.2025.102436_bib0025","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.jsbmb.2004.10.003","article-title":"Expression and function of androgen receptor coactivators in prostate cancer","volume":"92","author":"Culig","year":"2004","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.tranon.2025.102436_bib0026","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21061913","article-title":"The p38 pathway: from biology to cancer therapy","volume":"21","author":"Mart\u00ednez-Lim\u00f3n","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.tranon.2025.102436_bib0027","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/nrc2694","article-title":"Signal integration by JNK and p38 MAPK pathways in cancer development","volume":"9","author":"Wagner","year":"2009","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.tranon.2025.102436_bib0028","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/s12032-022-01689-w","article-title":"Long non-coding RNA AC245100.4 contributes to prostate cancer migration via regulating PAR2 and activating p38-MAPK pathway","volume":"39","author":"Liu","year":"2022","journal-title":"Med. Oncol."},{"key":"10.1016\/j.tranon.2025.102436_bib0029","doi-asserted-by":"crossref","first-page":"758","DOI":"10.3389\/fphar.2020.00758","article-title":"Pyrimethamine elicits antitumor effects on prostate cancer by inhibiting the p38-NF-\u03bab pathway","volume":"11","author":"Zhou","year":"2020","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.tranon.2025.102436_bib0030","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.22049","article-title":"Curcumin suppressed the prostate cancer by inhibiting JNK pathways via epigenetic regulation","volume":"32","author":"Zhao","year":"2018","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"10.1016\/j.tranon.2025.102436_bib0031","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/ptr.7614","article-title":"Gambogenic acid induces apoptosis and autophagy through ROS-mediated endoplasmic reticulum stress via JNK pathway in prostate cancer cells","volume":"37","author":"Wu","year":"2023","journal-title":"Phytother Res"},{"key":"10.1016\/j.tranon.2025.102436_bib0032","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/s41419-017-0207-0","article-title":"LanCL1 protects prostate cancer cells from oxidative stress via suppression of JNK pathway","volume":"9","author":"Wang","year":"2018","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.tranon.2025.102436_bib0033","doi-asserted-by":"crossref","first-page":"3240","DOI":"10.1080\/15548627.2023.2246356","article-title":"Lactate is a bridge linking glycolysis and autophagy through lactylation","volume":"19","author":"Sun","year":"2023","journal-title":"Autophagy"},{"key":"10.1016\/j.tranon.2025.102436_bib0034","doi-asserted-by":"crossref","first-page":"eadg4993","DOI":"10.1126\/sciadv.adg4993","article-title":"ULK1-mediated metabolic reprogramming regulates Vps34 lipid kinase activity by its lactylation","volume":"9","author":"Jia","year":"2023","journal-title":"Sci Adv"},{"key":"10.1016\/j.tranon.2025.102436_bib0035","first-page":"20","article-title":"Glut 1 in cancer cells and the inhibitory action of resveratrol as A potential therapeutic strategy","author":"Zambrano","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.tranon.2025.102436_bib0036","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.canlet.2020.11.018","article-title":"Pyruvate kinase M2 (PKM2) in cancer and cancer therapeutics","volume":"503","author":"Zhu","year":"2021","journal-title":"Cancer Lett."},{"key":"10.1016\/j.tranon.2025.102436_bib0037","article-title":"Recent advances on PKM2 inhibitors and activators in cancer applications","author":"Chen","year":"2023","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.tranon.2025.102436_bib0038","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s40170-021-00252-x","article-title":"Tumor suppressor SMAR1 regulates PKM alternative splicing by HDAC6-mediated deacetylation of PTBP1","volume":"9","author":"Choksi","year":"2021","journal-title":"Cancer Metab"}],"container-title":["Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523325001676?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523325001676?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T09:21:57Z","timestamp":1750152117000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936523325001676"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":38,"alternative-id":["S1936523325001676"],"URL":"https:\/\/doi.org\/10.1016\/j.tranon.2025.102436","relation":{},"ISSN":["1936-5233"],"issn-type":[{"value":"1936-5233","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"KAT5 promotes tumor growth in androgen-independent prostate cancer by facilitating aerobic glycolysis","name":"articletitle","label":"Article Title"},{"value":"Translational Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tranon.2025.102436","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102436"}}